ALLIANCEBERNSTEIN L.P. - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$64,801,000
+3.3%
1,811,609
-24.9%
0.05%
+1.9%
Q3 2014$62,712,000
-31.0%
2,412,013
-12.3%
0.05%
-31.2%
Q2 2014$90,937,000
+21.7%
2,751,488
+10.2%
0.08%
+18.5%
Q1 2014$74,713,000
+11.6%
2,496,246
+13.2%
0.06%
+8.3%
Q4 2013$66,922,000
+306.7%
2,204,276
+326.1%
0.06%
+275.0%
Q3 2013$16,456,000
+455.6%
517,332
+163.7%
0.02%
+433.3%
Q2 2013$2,962,000196,1580.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders